Literature DB >> 11860531

Immunology of the peritoneal cavity: relevance for host-tumor relation.

B Melichar1, R S Freedman.   

Abstract

The peritoneal membrane, formed by a single layer of mesothelial cells, lines the largest cavity of the human body. Anatomic structures of the peritoneal cavity, along with resident leukocyte populations, play an important role in the defense against microorganisms invading by breaching the gut integrity or ascending through the female genital tract. Local immune mechanisms in the peritoneal cavity are also important in patients undergoing peritoneal dialysis and in women with endometriosis. There is now extensive evidence demonstrating the significance of peritoneal immune mechanisms in the control of metastatic spread. Leukocytes belonging to both the innate and adaptive immune systems are present in the peritoneal cavity of normal subjects as well as in patients with intra-abdominal cancer. There is now increased understanding of the mechanisms that not only allow the tumor cells to escape the detection and destruction by the host immune system, but also to use the inflammatory mechanisms to promote tumor growth and spread inside the peritoneal cavity. Malignant ascites represents a model for the study of the interaction between tumor cells and the host immune system as well for the analysis of the tumor microenviroment. The peritoneal immune system may be stimulated by intraperitoneal administration of biologic agents. This peritoneal immunotherapy may be used for palliation of malignant ascites, or as a consolidation strategy in patients with minimal residual disease.

Entities:  

Mesh:

Year:  2002        PMID: 11860531     DOI: 10.1046/j.1525-1438.2002.01093.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  21 in total

1.  Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants.

Authors:  Keir M Balla; Geanncarlo Lugo-Villarino; Jan M Spitsbergen; David L Stachura; Yan Hu; Karina Bañuelos; Octavio Romo-Fewell; Raffi V Aroian; David Traver
Journal:  Blood       Date:  2010-08-16       Impact factor: 22.113

Review 2.  Role of the IL-33/ST2 receptor axis in ovarian cancer progression.

Authors:  Ning Liu; Jintong Chen; Yinghua Zhao; Mingyue Zhang; Li Piao; Siqing Wang; Ying Yue
Journal:  Oncol Lett       Date:  2021-04-29       Impact factor: 2.967

3.  Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors.

Authors:  Anna Kanerva; Anniina Koski; Ilkka Liikanen; Minna Oksanen; Timo Joensuu; Otto Hemminki; Juni Palmgren; Kari Hemminki; Akseli Hemminki
Journal:  Mol Ther       Date:  2014-11-10       Impact factor: 11.454

4.  The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascites.

Authors:  Yue-Qin Ai; Kai Cai; Jian-Hua Hu; Long-Wei Jiang; Yan-Rong Gao; Hua Zhao; Shao-Chang Jia
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 5.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

6.  Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.

Authors:  Diana Groza; Sebastian Gehrig; Pavol Kudela; Martin Holcmann; Christine Pirker; Carina Dinhof; Hemma H Schueffl; Marek Sramko; Julia Hoebart; Fatih Alioglu; Michael Grusch; Manfred Ogris; Werner Lubitz; Bernhard K Keppler; Irena Pashkunova-Martic; Christian R Kowol; Maria Sibilia; Walter Berger; Petra Heffeter
Journal:  Oncoimmunology       Date:  2018-02-16       Impact factor: 8.110

7.  Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm.

Authors:  Kyung Eun Kim; Young-Jun Koh; Bong-Hyun Jeon; Cholsoon Jang; Jinah Han; Raghu P Kataru; Reto A Schwendener; Jin-Man Kim; Gou Young Koh
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

8.  Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy.

Authors:  Kristian Taipale; Ilkka Liikanen; Anniina Koski; Raita Heiskanen; Anna Kanerva; Otto Hemminki; Minna Oksanen; Susanna Grönberg-Vähä-Koskela; Kari Hemminki; Timo Joensuu; Akseli Hemminki
Journal:  Mol Ther       Date:  2016-04-04       Impact factor: 11.454

Review 9.  The immunomodulating roles of glycoproteins in epithelial ovarian cancer.

Authors:  Manish S Patankar; Jennifer A A Gubbels; Mildred Felder; Joseph P Connor
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

10.  STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.

Authors:  Seung Joon Lee; Hannah Yang; Woo Ram Kim; Yu Seong Lee; Won Suk Lee; So Jung Kong; Hye Jin Lee; Jeong Hun Kim; Jaekyung Cheon; Beodeul Kang; Hong Jae Chon; Chan Kim
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.